Accuray Incorporated (ARAY) Actualités

Form 3 - Initial statement of beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance

Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance PR Newswire MADISON...

Form 8-K - Current report

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation...

Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025

Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025 PR Newswire MADISON, Wis...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Leonel Peralta to Join Accuray as Chief Operations Officer

Leonel Peralta to Join Accuray as Chief Operations Officer PR Newswire MADISON, Wis., Jan. 21, 2025 MADISON...

Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C System

Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and...

Form 4 - Statement of changes in beneficial ownership of securities

New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat

New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control...

Form 8-K - Current report